Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C

NCT01649245 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

5000

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Reiferon retard

Sponsor

MinaPharm Pharmaceuticals